source
- Cytokinetics heart drug scores in closely watched trialMyqorzo’s success in “non-obstructive” hypertrophic cardiomyopathy separates it from Bristol Myers Squibb’s rival Camzyos and opens up a multibillion-dollar market opportunity.BioPharma Dive · 3mo ago↗ source
- New Endometrial Targets Beyond HER2Interest in endometrial cancer extends well beyond HER2, and the faculty review a growing pipeline of antibody drug conjugates directed at additional targets. Discussion includes why TROPE2 and oth…onclive · 3mo ago↗ source
- Coordinating Care in Multiple Myeloma Across Practice Settingsonclive · 3mo ago↗ source